These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4378435)

  • 21. [Effect of propericiazine on behavior disorders of children and adolescents].
    Duche DJ
    Laval Med; 1970 Jun; 41(6):784-8. PubMed ID: 4396436
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of propericiazine (Neuleptil) on the Rorschach psychodiagnostic test in children during differential treatment].
    Ronco P; Mezzena G; Priora PM
    Minerva Med; 1968 Jul; 59(53):3003-7. PubMed ID: 4386141
    [No Abstract]   [Full Text] [Related]  

  • 23. [Bad character and Neuleptil. Apropos of a Belgian and Luxembourgian clinical experiment (1963-1964)].
    Bobon J; Gernay JM; Collard J; Goffioul F; Breulet M
    Acta Neurol Psychiatr Belg; 1968 Feb; 68(2):154-62. PubMed ID: 4387055
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical studies with propericiazine].
    Eckmann F; Immich H; Schäpperle O; Schwarz H
    Med Klin; 1966 Jan; 61(4):142-3. PubMed ID: 4383257
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of psychiatric inpatients with mesoridazine.
    Krout BM; Stone CB
    Psychosomatics; 1969; 10(4):244-8. PubMed ID: 5808616
    [No Abstract]   [Full Text] [Related]  

  • 26. [Electroencephalographic studies of a triflumethyl-phenothiazine derivative].
    Itil TM
    Arzneimittelforschung; 1965 Jul; 15(7):817-9. PubMed ID: 5898686
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical experiences with the neuroleptic butyryl-perazine (Wu 2791-AWD). Contribution to the syndromatic concept of endogenous psychoses].
    Kühne GE; Rennert H
    Z Arztl Fortbild (Jena); 1965 Feb; 59(3):140-6. PubMed ID: 5885796
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical expressions of aggressive behavior and their treatment].
    Montanini R; Mastruzzo A; Giovannucci M
    G Psichiatr Neuropatol; 1968; 96(3):567-76. PubMed ID: 4389866
    [No Abstract]   [Full Text] [Related]  

  • 29. [Geriatric experiences with Aolep].
    Jansen W
    Munch Med Wochenschr; 1966 Sep; 108(39):1926-8. PubMed ID: 6014871
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of the combination of propericiazine with chlorpromazine in the psychiatric field].
    Ostaptzeff G; Ostaptzeff-Lavoine M
    Ann Med Psychol (Paris); 1965 Dec; 123(5):655-64. PubMed ID: 4379140
    [No Abstract]   [Full Text] [Related]  

  • 31. Investigation of clinical outcome in a doctor's choice treatment setting.
    Overall JE; Tupin JP
    Dis Nerv Syst; 1969 May; 30(5):305-13. PubMed ID: 5771084
    [No Abstract]   [Full Text] [Related]  

  • 32. A controlled trial of propericiazine and chlorpromazine in "behaviour disorders".
    Rajotte P; Giard N; Tétreault L
    Curr Ther Res Clin Exp; 1966 Apr; 8(4):166-74. PubMed ID: 4379671
    [No Abstract]   [Full Text] [Related]  

  • 33. [Utilization of propericiazine in treatment of character disorders in mentally retarded children and adolescents].
    Vaneck L
    Rev Neuropsychiatr Infant; 1969 Aug; 17(8):557-61. PubMed ID: 4391428
    [No Abstract]   [Full Text] [Related]  

  • 34. [Neuleptil--a new neuroleptic drug. (Preliminary report)].
    Klosińska B; Soszyńska D; Wierzbicki T
    Neurol Neurochir Psychiatr Pol; 1966 Oct; 16(10):1163-6. PubMed ID: 4384652
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experiments with Neuleptil at the children's clinics of the Hospital Psiquiátrico de Jugueri].
    Bueno UP
    Hospital (Rio J); 1971 Jan; 79(1):111-22. PubMed ID: 4400607
    [No Abstract]   [Full Text] [Related]  

  • 36. factors influencing response to major tranquilizer medications.
    Kimbell I; Overall JE; Faibish GM; Pokorny AD
    Dis Nerv Syst; 1972 Apr; 33(4):223-30. PubMed ID: 5029910
    [No Abstract]   [Full Text] [Related]  

  • 37. [Ataractic treatment in psychiatry and general medicine. Review of drugs. 5].
    Hertrich O
    Fortschr Med; 1983 Jul; 101(26):1250, 1252. PubMed ID: 6884962
    [No Abstract]   [Full Text] [Related]  

  • 38. [Sociopsychological aspects of the introduction of a new psychotropic drug in a closed hospital service. Methodological reflections concerning 52 patients treated with propericiazine].
    Garneret N; Boissenin JM; Muyard JP
    Encephale; 1965; 54(3):265-83. PubMed ID: 4378570
    [No Abstract]   [Full Text] [Related]  

  • 39. [No. 233. Elementary prescriptions for therapy of states of excitement].
    Argenta G
    Clin Ter; 1971 Jul; 57(6):573-6. PubMed ID: 5136491
    [No Abstract]   [Full Text] [Related]  

  • 40. [Some results of the use of propericiazine (RP 8909) in the treatment of disorders of conduct and character in children and adolescents].
    Litinschi G; Fehervary E; Ciumăgeanu D
    Neurol Psihiatr Neurochir; 1970; 15(6):493-504. PubMed ID: 4396039
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.